View Filing Data

Document and Entity Information	6 Months Ended
Document and Entity Information	Oct. 01, 2011 shares
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 01, 2011
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2
Trading Symbol	HAE
Entity Registrant Name	HAEMONETICS CORP
Entity Central Index Key	0000313143
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	24,981,455

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2011	Oct. 02, 2010	Oct. 01, 2011	Oct. 02, 2010
Net revenues	$ 179,445	$ 166,833	$ 350,014	$ 329,872
Cost of goods sold	89,496	79,078	171,316	155,655
Gross profit	89,949	87,755	178,698	174,217
Operating expenses:
Research and development	10,350	7,954	18,959	15,875
Selling, general and administrative	62,613	52,790	118,844	107,144
Contingent consideration income	(1,580)	(1,894)	(1,580)	(1,894)
Total operating expenses	71,383	58,850	136,223	121,125
Operating income	18,566	28,905	42,475	53,092
Other income, net	445	254	230	442
Income before provision for income taxes	19,011	29,159	42,705	53,534
Provision for income taxes	5,131	7,821	11,877	14,277
Net income	$ 13,880	$ 21,338	$ 30,828	$ 39,257
Basic income per common share
Net income	$ 0.55	$ 0.86	$ 1.21	$ 1.58
Income per common share assuming dilution
Net income	$ 0.54	$ 0.85	$ 1.18	$ 1.54
Weighted average shares outstanding
Basic	25,418	24,686	25,575	24,913
Diluted	25,843	25,228	26,029	25,459

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Oct. 01, 2011

^[1]

Apr. 02, 2011

Current assets:

Cash and cash equivalents

$ 183,421

$ 196,707

Accounts receivable, less allowance of $2,283 at October 1, 2011 and $1,799 at April 2, 2011

129,242

127,166

Inventories, net

101,444

84,387

Deferred tax asset, net

9,790

9,674

Prepaid expenses and other current assets

17,203

30,897

Total current assets

441,100

448,831

Property, plant and equipment:

Land, building, and building improvements

55,127

52,359

Plant equipment and machinery

132,124

128,612

Office equipment and information technology

85,347

83,258

Haemonetics equipment

217,471

211,455

Total property, plant and equipment

490,069

475,684

Less: accumulated depreciation

(333,203)

(320,156)

Net property, plant and equipment

156,866

155,528

Other assets:

Intangible assets, less amortization of $49,320 at October 1, 2011 and $43,827 at April 2, 2011

98,847

101,789

Goodwill

115,582

115,367

Deferred tax asset, long term

1,353

1,291

Other long-term assets

9,974

10,458

Total other assets

225,756

228,905

Total assets

823,722

833,264

Current liabilities:

Notes payable and current maturities of long-term debt

3,080

913

Accounts payable

29,759

28,323

Accrued payroll and related costs

26,780

27,039

Accrued income taxes

5,361

6,033

Deferred tax liability

123

107

Other liabilities

45,703

46,256

Total current liabilities

110,806

108,671

Long-term debt, net of current maturities

3,332

3,966

Long-term deferred tax liability

18,005

18,669

Other long-term liabilities

13,302

15,822

Commitments and contingencies (Note 10)

Stockholders' equity:

Common stock, $.01 par value; Authorized - 150,000,000 shares; Issued and outstanding - 24,981,455 shares at October 1, 2011 and 25,660,393 shares at April 2, 2011

249

256

Additional paid-in capital

304,517

302,709

Retained earnings

364,726

373,630

Accumulated other comprehensive income

8,785

9,541

Total stockholders' equity

678,277

686,136

Total liabilities and stockholders' equity

$ 823,722

$ 833,264

[1]	(unaudited)

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands

Oct. 01, 2011

^[1]

Apr. 02, 2011

Accounts receivable, allowance

$ 2,283

$ 1,799

Intangible assets, amortization

$ 49,320

$ 43,827

Common stock, par value

$ 0.01

Common stock, Authorized

150,000,000

Common stock, Issued

24,981,455

25,660,393

Common stock, outstanding

24,981,455

25,660,393

[1]	(unaudited)

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands

6 Months Ended

Oct. 01, 2011

Oct. 02, 2010

Cash Flows from Operating Activities:

Net income

$ 30,828

$ 39,257

Non cash items:

Depreciation and amortization

24,619

24,690

Stock compensation expense

4,701

4,089

Loss on sales of property, plant and equipment

278

316

Unrealized loss from hedging activities

1,080

1,133

Contingent consideration income

(1,580)

(1,894)

Reversal of interest expense on contingent consideration

(574)

(493)

Change in operating assets and liabilities:

Increase in accounts receivable, net

(1,332)

(837)

Increase in inventories

(15,390)

(3,900)

Decrease in prepaid income taxes

12,283

6,849

Increase in other assets and other long-term liabilities

(1,267)

(3,727)

Tax benefit on exercise of stock options

952

946

Decrease in accounts payable and accrued expenses

(2,059)

(22,143)

Net cash provided by operating activities

52,539

44,286

Cash Flows from Investing Activities:

Capital expenditures on property, plant and equipment

(23,843)

(24,088)

Proceeds from sale of property, plant and equipment

130

262

Net cash used in investing activities

(23,713)

(23,826)

Cash Flows from Financing Activities:

Payments on long-term real estate mortgage

(634)

(166)

Net increase/(decrease) in short-term loans

1,992

(5,249)

Employee stock purchase plan

1,847

1,645

Exercise of stock options

4,707

5,841

Excess tax benefit on exercise of stock options

333

628

Share repurchase

(49,998)

(50,000)

Net cash used in financing activities

(41,753)

(47,301)

Effect of exchange rates on cash and cash equivalents

(359)

328

Net decrease in Cash and Cash Equivalents

(13,286)

(26,513)

Cash and Cash Equivalents at Beginning of Year

196,707

141,562

Cash and Cash Equivalents at End of Period

183,421

^[1]

115,049

Non-cash Investing and Financing Activities:

Transfers from inventory to fixed assets for placements of Haemonetics equipment

6,292

3,710

Supplemental Disclosures of Cash Flow Information:

Interest paid

220

251

Income taxes paid

$ 2,288

$ 6,941

[1]	(unaudited)

BASIS OF PRESENTATION

6 Months Ended

Oct. 01, 2011

BASIS OF PRESENTATION

1. BASIS OF PRESENTATION

Our accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated. Certain reclassifications were made to prior year balances to conform to the presentation of the financial statements for the six months ended October 1, 2011. Operating results for the six month period ended October 1, 2011 are not necessarily indicative of the results that may be expected for the full fiscal year ending March 31, 2012, or any other interim period. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and footnotes included in our annual report on Form 10-K for the fiscal year ended April 2, 2011.

The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated, and these financial statements reflect those material items that arose after the balance sheet date but prior to the issuance of the financial statements that would be considered recognized subsequent events. There were no material recognized subsequent events recorded in the October 1, 2011 consolidated financial statements.

Our fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2012 and 2011 include 52 weeks with all four quarters each having 13 weeks.

RECENT ACCOUNTING PRONOUNCEMENTS

6 Months Ended

Oct. 01, 2011

RECENT ACCOUNTING PRONOUNCEMENTS

2. RECENT ACCOUNTING PRONOUNCEMENTS

In May 2011, the FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. Update No. 2011-04 updates the accounting guidance related to fair value measurements that results in a consistent definition of fair value and common requirements for measurement of and disclosure about fair value between U.S. GAAP and International Financial Reporting Standards (IFRS). The updated guidance is effective for interim and annual periods beginning after December 15, 2011. Early application is not permitted. We are currently evaluating the potential impact of Update No. 2011-04 on our consolidated financial statements. This statement is effective for our fourth quarter of fiscal year 2012.

In June 2011, the FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. Update No. 2011-05 updates the disclosure requirements for comprehensive income to include total comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The updated guidance does not affect how earnings per share is calculated or presented. The updated guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011, and should be applied retrospectively. Early adoption is permitted and amendments do not require any transition disclosures. This statement is effective in our first quarter of fiscal year 2013.

In September 2011, the FASB issued Accounting Standards Update No. 2011-08, Intangibles — Goodwill and Other (Topic 350). ASU 2011-08 allows entities to first assess qualitatively whether it is necessary to perform the two-step goodwill impairment test. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative two-step goodwill impairment test is required. An entity has the unconditional option to bypass the qualitative assessment and proceed directly to performing the first step of the goodwill impairment test. The Company anticipates that the adoption of this standard will not have a material impact on its consolidated financial statements and footnote disclosures.

Standards Implemented

In October 2009, the FASB issued Accounting Standards Update No. 2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements, and Accounting Standards Update No. 2009-14, Software (Topic 985): Certain Revenue Arrangements That Include Software (the “Updates”). The Updates provide guidance on arrangements that include software elements, including tangible products that have software components that are essential to the functionality of the tangible product and will no longer be within the scope of the software revenue recognition guidance, and software-enabled products that will now be subject to other relevant revenue recognition guidance. The Updates also provide authoritative guidance on revenue arrangements with multiple deliverables that are outside the scope of the software revenue recognition guidance. Under the new guidance, when vendor specific objective evidence or third party evidence of fair value for deliverables in an arrangement cannot be determined, a best estimate of the selling price is required to allocate arrangement consideration using the relative selling price method. The Updates also include new disclosure requirements on how the application of the relative selling price method affects the timing and amount of revenue recognition. On April 3, 2011, the Company adopted this guidance, which did not have a material impact on our financial position or results of operations.

In December 2010, the FASB issued Accounting Standards Update No. 2010-29, Business Combinations (Topic 805): Disclosure of Supplementary Pro Forma Information for Business Combinations. Update No. 2010-29 clarifies paragraph 805-10-50-2(h) to require public entities that enter into business combinations that are material on an individual or aggregate basis to disclose pro forma information for such business combinations that occurred in the current reporting period, including pro forma revenue and earnings of the combined entity as though the acquisition date had been as of the beginning of the comparable prior annual reporting period only. We did not complete any material business acquisitions during the six months ended October 1, 2011 thus the disclosure requirements were not applicable for the period.

EARNINGS PER SHARE ("EPS")

6 Months Ended

Oct. 01, 2011

EARNINGS PER SHARE ("EPS")

3. EARNINGS PER SHARE (“EPS”)

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. Basic EPS is computed by dividing net income by weighted average shares outstanding. Diluted EPS includes the effect of potentially dilutive common shares.


	Three Months Ended
	October 1, 2011		October 2, 2010
	(in thousands, except per share amounts)
Basic EPS
Net income	$	13,880	$	21,338

Weighted average shares		25,418		24,686

Basic income per share	$	0.55	$	0.86


Diluted EPS
Net income	$	13,880	$	21,338

Basic weighted average shares		25,418		24,686
Net effect of common stock equivalents		425		542

Diluted weighted average shares		25,843		25,228

Diluted income per share	$	0.54	$	0.85


	Six Months Ended
	October 1, 2011		October 2, 2010
	(in thousands, except per share amounts)
Basic EPS
Net income	$	30,828	$	39,257

Weighted average shares		25,575		24,913

Basic income per share	$	1.21	$	1.58


Diluted EPS
Net income	$	30,828	$	39,257

Basic weighted average shares		25,575		24,913
Net effect of common stock equivalents		454		546

Diluted weighted average shares		26,029		25,459

Diluted income per share	$	1.18	$	1.54

Weighted average shares outstanding, assuming dilution, excludes the impact of 0.4 million and 1.1 million stock options for the second quarter of fiscal year 2012 and 2011, respectively, 0.4 million and 0.8 million stock options for the first six months of fiscal year 2012 and 2011, respectively, because these securities were anti-dilutive during the noted periods.

STOCK-BASED COMPENSATION

6 Months Ended

Oct. 01, 2011

STOCK-BASED COMPENSATION

4. STOCK-BASED COMPENSATION

Stock-based compensation expense of $4.7 million and $4.1 million was recognized for the six months ended October 1, 2011 and October 2, 2010, respectively. The related income tax benefit recognized was $1.3 million for the six months ended October 1, 2011 and October 2, 2010.

The weighted average fair value for our options granted in the first six months of fiscal year 2012 and 2011 was $18.27 and $16.89, respectively. The assumptions utilized for estimating the fair value of option grants during the periods presented are as follows:


	Six Months Ended
	October 1, 2011			October 2, 2010
Stock Options Black-Scholes assumptions (weighted average):
Volatility		27.42	%		28.33	%
Expected life (years)		4.9			4.9
Risk-free interest rate		1.60	%		2.43	%
Dividend yield		0.00	%		0.00	%

During the six months ended October 1, 2011 and October 2, 2010, there were 41,067 and 35,992 shares, respectively, purchased under the ESPP. They were purchased at $46.80 and $45.70 per share, respectively, under the ESPP.

STOCK-BASED COMPENSATION - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Oct. 01, 2011	Oct. 02, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized	$ 4.7	$ 4.1
Income tax benefit recognized related to Stock-based compensation	$ 1.3	$ 1.3
Weighted average fair value of options granted	$ 18.27	$ 16.89
Shares purchased under the ESPP	41,067	35,992
Shares purchased under the ESPP, value per share	$ 46.80	$ 45.70

Assumptions Utilized for Estimating Fair Value of Option Grants (Detail) - Year	6 Months Ended
	Oct. 01, 2011	Oct. 02, 2010
Stock Options Black-Scholes assumptions (weighted average):
Volatility	27.42%	28.33%
Expected life (years)	4.9	4.9
Risk-free interest rate	1.60%	2.43%
Dividend yield	0.00%	0.00%

Product Warranties Liabilities (Detail) - USD ($) $ in Thousands	6 Months Ended
	Oct. 01, 2011	Oct. 02, 2010
Product Liability Contingency [Line Items]
Warranty accrual as of the beginning of the period	$ 1,273	$ 903
Warranty provision	603	699
Warranty spending	(856)	(940)
Warranty accrual as of the end of the period	$ 1,020	$ 662

DERIVATIVES AND FAIR VALUE MEASUREMENTS - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Sep. 30, 2011	Oct. 01, 2011	Oct. 02, 2010	Oct. 01, 2011	Oct. 02, 2010	Apr. 02, 2011
Derivative [Line Items]
Maturity period for foreign currency contracts		1 year		1 year
Designated foreign currency hedge contracts outstanding		$ 153,600		$ 153,600		$ 154,800
Non-designated foreign currency hedge contracts outstanding		48,200		48,200		45,900
Contingent consideration income		1,580	$ 1,894	1,580	$ 1,894
Contingent consideration payment recorded in selling, general and administrative	$ 700
Foreign Exchange Contract
Derivative [Line Items]
Amount of losses reclassified to earnings within the next twelve months				2,896
Amount of Loss Recognized in OCI (Effective Portion)				(2,889)
Designated as Hedging Instrument
Derivative [Line Items]
Amount of losses reclassified to earnings within the next twelve months				2,900
Designated as Hedging Instrument \| Foreign Exchange Contract
Derivative [Line Items]
Amount of Loss Recognized in OCI (Effective Portion)				2,900
Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract
Derivative [Line Items]
Recognized net losses in earnings on cash flow hedges				$ 2,900	$ 4,100
Foreign Country
Derivative [Line Items]
Percentage of sales generated outside the US				51.00%
Mortgage Loans on Real Estate
Derivative [Line Items]
Liabilities, Fair Value Disclosure		$ 3,700		$ 3,700		$ 4,100

Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Oct. 01, 2011	Apr. 02, 2011
Derivative Assets:
Derivative Assets	$ 1,541	$ 2,563
Derivative Liabilities:
Derivative Liabilities	4,185	4,174
Cash Flow Hedging \| Foreign Exchange Contract \| Other Current Assets
Derivative Assets:
Derivative Assets	1,541	2,563
Cash Flow Hedging \| Foreign Exchange Contract \| Other Current Liabilities
Derivative Liabilities:
Derivative Liabilities	$ 4,185	$ 4,174

Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Measurements, Recurring $ in Thousands	Oct. 01, 2011 USD ($)
Assets
Money market funds	$ 143,035
Foreign currency hedge contracts	1,541
Assets, Fair Value Disclosure, Total	144,576
Liabilities
Foreign currency hedge contracts	4,185
Liabilities, Fair Value Disclosure	4,185
Fair Value, Inputs, Level 1
Assets
Money market funds	143,035
Assets, Fair Value Disclosure, Total	143,035
Fair Value, Inputs, Level 2
Assets
Foreign currency hedge contracts	1,541
Assets, Fair Value Disclosure, Total	1,541
Liabilities
Foreign currency hedge contracts	4,185
Liabilities, Fair Value Disclosure	$ 4,185

INCOME TAXES - Additional Information (Detail)	3 Months Ended	6 Months Ended
INCOME TAXES - Additional Information (Detail)	Oct. 01, 2011	Oct. 01, 2011
Income Taxes [Line Items]
Reported tax rate	27.00%	27.80%

COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) - High Separation Core Bowl - USD ($) $ in Millions	3 Months Ended
	Jul. 02, 2011	Oct. 01, 2011
Loss Contingencies [Line Items]
Aggregate claims submitted by customers	$ 8.5
Accrued loss contingency liability		$ 2.4

REORGANIZATION - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Oct. 01, 2011	Oct. 02, 2010
Restructuring Cost and Reserve [Line Items]
Restructuring charges incurred	$ 3,008	$ 1,400
Minimum
Restructuring Cost and Reserve [Line Items]
Anticipate additional restructuring charges over remaining six months of fiscal year 2012	5,000
Maximum
Restructuring Cost and Reserve [Line Items]
Anticipate additional restructuring charges over remaining six months of fiscal year 2012	$ 6,000